Secondary Statistical Analyses Sample Clauses

Secondary Statistical Analyses. Additionally, all cases were analyzed by site of infection, location (inpatient or outpatient) of positive culture, and season of infection. The same season definitions were used for infection as were used for vitamin D measurement (winter: December- February, spring: March-May, summer: June-August, and fall: September-October). Infections that occurred in 2005 were excluded from this analysis, since infections were only recorded for part of this year. Because the first serum 25(OH)D level measured for each patient was used in the analysis, and each case did not simultaneously present with an MRSA infection, the number of days between positive MRSA culture (day 0) and serum 25(OH)D recording was determined. In addition, all vitamin D determinations in the database were used to calculate the median serum 25(OH)D for all subjects by year. Because the patient population at the VAMC is not necessarily representative of the general population, additional analyses were carried out in order to further characterize the patients included in the study. Both age and race were analyzed by the other patient characteristics.
AutoNDA by SimpleDocs
Secondary Statistical Analyses. Most cases (70.1%) experienced one infection while relatively small percentages of cases experienced 2 to 5 infections over the duration of the study period (Figure 1). The most common site of MRSA infection was skin and soft tissue (n=232; 57.9%), followed by genitourinary tract (n=53; 13.2%), bloodstream and cardiovascular system (n=37; 9.2%), respiratory (n=32; 8.0%), bone and joint (n=22; 5.5%), surgical site (n=13; 3.2%), eye/ear/nose/throat/mouth (n=10; 2.5%), reproductive tract (n=1; 0.3%), and gastrointestinal tract (n=1; 0.3%) (Figure 2). Almost all of the MRSA infections were diagnosed in the outpatient setting (n=366; 91.3%) as opposed to the inpatient setting (n=35, 9%). There was no significant difference in frequency of infection by season (p=0.1343) (Table VIII). The number of days between vitamin D determination and positive MRSA culture ranged from 1669 days (approximately 4.57 years) before infection to 1360 days (3.72 years) after the infection with a median of 77 days prior to infection (Figure 3). Median vitamin D levels were approximately the same from 2007 to 2009, and then dropped significantly to 19 ng/mL in 2010 (p<0.0001) (Table IX). In this group of veterans, males were significantly older than females (p<0.0001), white subjects were significantly older than black subjects and subjects in the “other race” category (p<0.0001), and non-Hispanics were significantly older than Hispanics (p=0.0308) (Table X). BMI related inversely to age (p<0.0001). HIV positive individuals were significantly younger than HIV negative subjects (p<0.0001). Race was significantly associated with gender (p<0.0001), ethnicity (p<0.0001), and HIV status (p<0.0001) (Table XI). The other race category was comprised of the highest percentage of females (29.8%) and Hispanic subjects (7.0%). Of the black subjects, 23.2% were HIV positive, which was significantly more than in the white and other race categories (6.9% and 0.0%, respectively).

Related to Secondary Statistical Analyses

  • Statistical Analysis 31 F-tests and t-tests will be used to analyze OV and Quality Acceptance data. The F-test is a 32 comparison of variances to determine if the OV and Quality Acceptance population variances 33 are equal. The t-test is a comparison of means to determine if the OV and Quality Acceptance 34 population means are equal. In addition to these two types of analyses, independent verification 35 and observation verification will also be used to validate the Quality Acceptance test results.

  • Statistical Sampling Documentation a. A copy of the printout of the random numbers generated by the “Random Numbers” function of the statistical sampling software used by the IRO.

  • Statistical Information Any third-party statistical and market-related data included in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate in all material respects.

  • Data Analysis In the meeting, the analysis that has led the College President to conclude that a reduction- in-force in the FSA at that College may be necessary will be shared. The analysis will include but is not limited to the following: ● Relationship of the FSA to the mission, vision, values, and strategic plan of the College and district ● External requirement for the services provided by the FSA such as accreditation or intergovernmental agreements ● Annual instructional load (as applicable) ● Percentage of annual instructional load taught by Residential Faculty (as applicable) ● Fall Full-Time Student Equivalent (FFTE) inclusive of dual enrollment ● Number of Residential Faculty teaching/working in the FSA ● Number of Residential Faculty whose primary FSA is the FSA being analyzed ● Revenue trends over five years for the FSA including but not limited to tuition and fees ● Expenditure trends over five years for the FSA including but not limited to personnel and capital ● Account balances for any fees accounts within the FSA ● Cost/benefit analysis of reducing all non-Residential Faculty plus one Residential Faculty within the FSA ● An explanation of the problem that reducing the number of faculty in the FSA would solve ● The list of potential Residential Faculty that are at risk of layoff as determined by the Vice Chancellor of Human Resources ● Other relevant information, as requested

  • Program Evaluation The School District and the College will develop a plan for the evaluation of the Dual Credit program to be completed each year. The evaluation will include, but is not limited to, disaggregated attendance and retention rates, GPA of high-school-credit-only courses and college courses, satisfactory progress in college courses, state assessment results, SAT/ACT, as applicable, TSIA readiness by grade level, and adequate progress toward the college-readiness of the students in the program. The School District commits to collecting longitudinal data as specified by the College, and making data and performance outcomes available to the College upon request. HB 1638 and SACSCOC require the collection of data points to be longitudinally captured by the School District, in collaboration with the College, will include, at minimum: student enrollment, GPA, retention, persistence, completion, transfer and scholarships. School District will provide parent contact and demographic information to the College upon request for targeted marketing of degree completion or workforce development information to parents of Students. School District agrees to obtain valid FERPA releases drafted to support the supply of such data if deemed required by counsel to either School District or the College. The College conducts and reports regular and ongoing evaluations of the Dual Credit program effectiveness and uses the results for continuous improvement.

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • Analyses investigations, surveys and reports described in Section 5 above as Reimbursable Services;

  • Medical Reports The following applies to all employees: The Employer agrees to pay the fee for medical reports required by the Employer for Sick Leave or Weekly Indemnity provisions to a maximum of fifty dollars ($50.00).

  • Technical Reports deliver to the Agent, and shall procure that the Manager shall deliver to the Agent, on request copies of the latest complete technical reports in respect of the Vessels.

  • MEDICAL REPORT The Agency/Department Head as a condition of granting sick leave with pay, may require medical evidence of sickness or injury acceptable to the Agency/Department. The acceptable medical evidence must be obtained from a medical practitioner currently treating the employee or the employee’s family member.

Time is Money Join Law Insider Premium to draft better contracts faster.